Dorothy M. Grogono

Dorothy M. Grogono

Auto-generated profile, based on publicly available information

Dorothy M. Grogono

Cambridge Centre for Lung Infection, Royal Papworth Hospital, Cambridge, UK

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2013 in The Lancet
Verified
Journal Article
Open access
JBJosephine M Bryant
Josephine M Bryant
DGDorothy M Grogono
Dorothy M Grogono
DGDaniel Greaves
Daniel Greaves
JFJuliet Foweraker
Juliet Foweraker
IRIain Roddick
Iain Roddick
RFR Andres Floto
R Andres Floto
Increasing numbers of individuals with cystic fibrosis are becoming infected with the multidrug-resistant non-tuberculous mycobacterium (NTM) Mycobacterium abscessus, which causes progressive lung damage and is extremely challenging to treat. How this organism is acquired is not currently known, but there is growing concern that person-to-person transmission could occur. We aimed to define the mechanisms of acquisition of M abscessus in individuals with cystic fibrosis. Whole genome sequencing and antimicrobial susceptibility testing were done on 168 consecutive isolates of M abscessus from 31 patients attending an adult cystic fibrosis centre in the UK between 2007 and 2011. In parallel, we undertook detailed environmental testing for NTM and defined potential opportunities for transmission between patients both in and out of hospital using epidemiological data and social network analysis. Phylogenetic analysis revealed two clustered outbreaks of near-identical isolates of the M abscessus subspecies massiliense (from 11 patients), differing by less than ten base pairs. This variation represents less diversity than that seen within isolates from a single individual, strongly indicating between-patient transmission. All patients within these clusters had numerous opportunities for within-hospital transmission from other individuals, while comprehensive environmental sampling, initiated during the outbreak, failed to detect any potential point source of NTM infection. The clusters of M abscessus subspecies massiliense showed evidence of transmission of mutations acquired during infection of an individual to other patients. Thus, isolates with constitutive resistance to amikacin and clarithromycin were isolated from several individuals never previously exposed to long-term macrolides or aminoglycosides, further indicating cross-infection. Whole genome sequencing has revealed frequent transmission of multidrug resistant NTM between patients with cystic fibrosis despite conventional cross-infection measures. Although the exact transmission route is yet to be established, our epidemiological analysis suggests that it could be indirect. The Wellcome Trust, Papworth Hospital, NIHR Cambridge Biomedical Research Centre, UK Health Protection Agency, Medical Research Council, and the UKCRC Translational Infection Research Initiative.

11 November 2016 in Science
Verified
Journal Article
Open access
PDF file
JBJosephine M. Bryant
Josephine M. Bryant
DGDorothy M. Grogono
Dorothy M. Grogono
DRDaniela Rodriguez-Rincon
Daniela Rodriguez-Rincon
IEIsobel Everall
Isobel Everall
KBKaren P. Brown
Karen P. Brown
RFR. Andres Floto
R. Andres Floto
Global spread of aggressive mycobacteria: Many mycobacteria, in addition to those causing leprosy and tuberculosis, are capable of infecting humans. Some can be particularly dangerous in patients suffering from immunosuppression or chronic disease, such as cystic fibrosis (CF). Bryant et al. observed clusters of near-identical isolates of drug-resistant Mycobacterium abscessus in patients reporting to CF clinics. The similarity of the isolates suggests transmission between patients, rather than environmental acquisition. Although this bacterium is renowned for its environmental resilience, the mechanism for its long-distance transmission among the global CF patient community remains a puzzle. Science , this issue p. 751

30 April 2021 in Science
Verified
Journal Article
Closed access
PDF file
JBJosephine M. Bryant
Josephine M. Bryant
KBKaren P. Brown
Karen P. Brown
SBSophie Burbaud
Sophie Burbaud
IEIsobel Everall
Isobel Everall
Juan BelardinelliJuan Belardinelli
Juan Belardinelli
RFR. Andres Floto
R. Andres Floto
Jump starting pathogen evolution: Mycobacteria are mostly environmental saprotrophs, but during human history, some have become our pathogens. In the past 50 years or so, intractable and virulent infections of Mycobacterium abscessus have emerged in people with cystic fibrosis. Bryant et al. investigated how these mycobacteria have evolved into human pathogens so quickly (see the Perspective by Brugha and Spencer). Chronic infections in the lung offer plenty of evolutionary scope for the emergence of virulent clones after horizontal gene transfer and hypermutation. Pathogens are acquired by environmental contamination, which leaves open a window for clinical control because the most virulent clones survive poorly outside the body. Therefore, immediate treatment and enhanced infection-control measures for M. abscessus cases could reduce opportunities for the evolution of direct person-to-person transmission. Science , this issue p. eabb8699 ; see also p. 465

31 October 2014 in Science
Verified
Journal Article
Closed access
PDF file
LHLucy Hepburn
Lucy Hepburn
TPTomasz K. Prajsnar
Tomasz K. Prajsnar
CKCatherine Klapholz
Catherine Klapholz
PMPablo Moreno
Pablo Moreno
CLCatherine A. Loynes
Catherine A. Loynes
RFR. Andres Floto
R. Andres Floto
Overcoming staph infections is hardwired: Several evolutionarily conserved components of antistaphylococcal immunity have been identified, using Drosophila as a model organism. However, no vertebrate ortholog has been identified for the Toll ligand Spaetzle, which plays a key role in controlling gram-positive infection in flies. Hepburn et al. have now identified NGF-β as a functional equivalent to Spaetzle in vertebrates. NGF-β acts as a paracrine “alarmin” orchestrating macrophage and neutrophil responses to S. aureus infection. People with deleterious mutations in genes encoding NGF-β or its high-affinity receptor TRKA are predisposed to recurrent and severe staph infections. S. aureus proteins selectively trigger macrophage production of NGF-β, which enhances uptake and superoxide-dependent killing of S. aureus , stimulates proinflammatory cytokine production, and promotes neutrophil recruitment. Moreover, TrkA silencing in vivo increases susceptibility to S. aureus . Thus, the NGF-β–TRKA pathway is a critical, evolutionarily conserved component of vertebrate immunity to S. aureus infection. Science , this issue p. 641

1 July 2015 in Journal of Clinical Microbiology
Verified
Journal Article
Open access
PDF file
TPTheofano Panagea
Theofano Panagea
DPDavid H. Pincus
David H. Pincus
DGDorothy Grogono
Dorothy Grogono
MJMelissa Jones
Melissa Jones
JBJosephine Bryant
Josephine Bryant
PGPeter Gilligan
Peter Gilligan
We determined that the Vitek MS Plus matrix-assisted laser desorption ionization–time of flight mass spectrometry using research-use-only (RUO) v.4.12 and in vitro -diagnostic (IVD) v.3.0 databases accurately identified 41 Mycobacterium abscessus subsp. abscessus and 13 M. abscessus subsp. massiliense isolates identified by whole-genome sequencing to the species but not the subspecies level, from Middlebrook 7H11 and Burkholderia cepacia selective agars. Peak analysis revealed three peaks potentially able to differentiate between subspecies.

9 January 2026 in Nature Microbiology
Verified
Journal Article
Open access
PDF file
AJAlexander Jovanovic
Alexander Jovanovic
FBFrederick K. Bright
Frederick K. Bright
ASAhmad Sadeghi
Ahmad Sadeghi
BWBasil Wicki
Basil Wicki
SMSantiago E. Caño Muñiz
Santiago E. Caño Muñiz
LBLucas Boeck
Lucas Boeck
In vitro antibiotic testing is important for guiding therapy and drug development. Current methods are focused on growth inhibition in bulk bacterial populations but often fail to accurately predict treatment responses. Here we introduce Antimicrobial Single-Cell Testing (ASCT), a large-scale live-cell imaging approach that quantifies bacterial killing in real time at single-cell resolution. By tracking over 140 million mycobacteria and analysing ~20,000 time–kill curves, we identify key determinants of antibiotic killing and its clinical relevance. For Mycobacterium tuberculosis , we found that drug-specific killing dynamics in starved bacteria, rather than growth inhibition or killing of growing cells, predict regimen efficacy in mice and humans. Extending this approach to Mycobacterium abscessus and comparing 405 bacterial strains, we show that antibiotic killing is also a genetically encoded bacterial trait (drug tolerance). We demonstrate that tolerance patterns cluster by antibiotic targets, identify a phage protein that modulates antibiotic killing, and show that strain-specific killing dynamics are associated with individual patient outcomes independent of drug resistance. Together, these findings establish a framework that reveals how drug properties and bacterial diversity shape treatment responses, offering a path to more effective and personalized therapies.